About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Focus
Pipeline
Patients
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
23rd Congress of the European Hematology Association (EHA)
23rd Congress of the European Hematology Association (EHA)
June 2018
Phase 2 Study of X4P-001: A Targeted Oral Therapy for Patients with WHIM Syndrome
© 2023 X4 Pharmaceuticals, Inc. All rights reserved.
Terms of Use
|
Privacy Policy